Jason Kelly Biography and Net Worth

Insider of Ginkgo Bioworks

Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. He has served as a member of our board of directors since Ginkgo’s founding in 2008. He has also served as a director of CM Life Sciences II Inc. (Nasdaq: CMII), a special purpose acquisition company with a focus on the life sciences sector, since its initial public offering in February 2021. Dr. Kelly has a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from the Massachusetts Institute of Technology.

What is Jason R. Kelly's net worth?: The estimated net worth of Jason R. Kelly is at least $4.27 million as of April 8th, 2026. Dr. Kelly owns 426,250 shares of Ginkgo Bioworks stock worth more than $4,266,336 as of May 7th. This net worth estimate does not reflect any other investments that Dr. Kelly may own. Learn More about Jason R. Kelly's net worth.
How do I contact Jason R. Kelly?: The corporate mailing address for Dr. Kelly and other Ginkgo Bioworks executives is 955 Fifth Avenue, New York NY, 10075. Ginkgo Bioworks can also be reached via phone at 877-442-5362 and via email at [email protected]. Learn More on Jason R. Kelly's contact information.
Has Jason R. Kelly been buying or selling shares of Ginkgo Bioworks?: In the last ninety days, Jason R. Kelly has sold $1,374,822.75 in Ginkgo Bioworks stock. Most recently, Jason R. Kelly sold 109,767 shares of the business's stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $6.40, for a transaction totalling $702,508.80. Following the completion of the sale, the insider now directly owns 316,483 shares of the company's stock, valued at $2,025,491.20. Learn More on Jason R. Kelly's trading history.
Who are Ginkgo Bioworks' active insiders?: Ginkgo Bioworks' insider roster includes Barry Canton (Major Shareholder), Steven Coen (Chief Financial Officer), Marijn Dekkers (Director), Mark Dmytruk (Insider), Christian Henry (Director), Jason Kelly (Insider), Reshma Shetty (Insider), and Harry Sloan (Director). Learn More on Ginkgo Bioworks' active insiders.
Are insiders buying or selling shares of Ginkgo Bioworks?: In the last twelve months, insiders at the sold shares 16 times. They sold a total of 552,694 shares worth more than $3,676,922.54. The most recent insider tranaction occured on April, 17th when insider Steven P Coen sold 324 shares worth more than $2,575.80. Insiders at Ginkgo Bioworks own 9.7% of the company. Learn More about insider trades at Ginkgo Bioworks.
Information on this page was last updated on 4/17/2026.

Jason R. Kelly Insider Trading History at Ginkgo Bioworks

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/9/2026	Sell	109,767	$6.40	$702,508.80	316,483
4/8/2026	Sell	97,015	$6.93	$672,313.95	426,250
1/3/2024	Sell	100,000	$1.54	$154,000.00	3,994,680
12/20/2023	Sell	100,000	$1.79	$179,000.00	4,194,680
12/13/2023	Sell	99,020	$1.34	$132,686.80	4,395,660
12/6/2023	Sell	100,000	$1.32	$132,000.00	4,594,680
11/24/2023	Sell	100,000	$1.41	$141,000.00	4,894,680
11/22/2023	Sell	100,000	$1.40	$140,000.00	4,994,680
11/15/2023	Sell	100,000	$1.54	$154,000.00	5,194,680
10/18/2023	Sell	100,000	$1.69	$169,000.00	5,994,680
10/11/2023	Sell	100,000	$1.76	$176,000.00	6,194,680
9/27/2023	Sell	100,000	$1.82	$182,000.00	6,594,680
9/7/2023	Sell	100,000	$2.13	$213,000.00	7,094,680
8/30/2023	Sell	100,000	$2.21	$221,000.00	7,394,680
8/23/2023	Sell	100,000	$1.74	$174,000.00	7,594,680
7/26/2023	Sell	100,000	$2.38	$238,000.00	8,394,680
7/12/2023	Sell	100,000	$2.09	$209,000.00	8,794,680
7/5/2023	Sell	100,000	$1.81	$181,000.00	8,994,680
6/28/2023	Sell	100,000	$1.70	$170,000.00	9,194,680
6/14/2023	Sell	100,000	$1.95	$195,000.00	9,594,680
1/25/2023	Sell	258,748	$1.73	$447,634.04	14,947,040
1/23/2023	Sell	143,807	$1.75	$251,662.25	15,359,782
1/17/2023	Sell	151,531	$1.86	$281,847.66	16,172,783
1/11/2023	Sell	246,449	$1.61	$396,782.89	16,734,634
12/23/2022	Sell	203,349	$1.64	$333,492.36	17,787,655
12/19/2022	Sell	206,449	$1.67	$344,769.83	18,802,367
12/7/2022	Sell	100,909	$1.69	$170,536.21	19,708,432
11/21/2022	Sell	103,765	$2.10	$217,906.50	20,519,888
11/18/2022	Sell	98,562	$2.17	$213,879.54	20,623,653
11/16/2022	Sell	219,089	$2.42	$530,195.38	20,943,617
11/11/2022	Sell	197,964	$2.65	$524,604.60	21,583,782
11/9/2022	Sell	207,960	$2.43	$505,342.80	21,967,774
11/7/2022	Sell	205,809	$2.42	$498,057.78	22,369,350
10/24/2022	Sell	206,504	$2.48	$512,129.92	23,954,637
10/21/2022	Sell	201,371	$2.44	$491,345.24	24,161,141
10/19/2022	Sell	211,829	$2.50	$529,572.50	24,559,233
10/13/2022	Sell	207,271	$2.74	$567,922.54	25,380,378

Jason R. Kelly Buying and Selling Activity at Ginkgo Bioworks

Ginkgo Bioworks Company Overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $10.01

$9.73

$10.34

50 Day Range

MA: $7.29

$5.49

$10.11

2 Week Range

Now: $10.01

$5.37

$17.58

Volume

399,956 shs

Average Volume

1,151,532 shs

Market Capitalization

$619.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77